` MGRM (Monogram Orthopaedics Inc) vs S&P 500 Comparison - Alpha Spread

M
MGRM
vs
S&P 500

Over the past 12 months, MGRM has significantly outperformed S&P 500, delivering a return of +117% compared to the S&P 500's +12% growth.

Stocks Performance
MGRM vs S&P 500

Loading
MGRM
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
MGRM vs S&P 500

Performance Gap Between MGRM and GSPC
HIDDEN
Show

Performance By Year
MGRM vs S&P 500

Loading
MGRM
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Monogram Orthopaedics Inc vs Peers

S&P 500
MGRM
SYK
STE
DIM
COLO B
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Monogram Orthopaedics Inc
Glance View

Market Cap
243.8m USD
Industry
N/A

Monogram Orthopaedics Inc is a US-based company operating in industry. The company is headquartered in Brooklyn, New York. The company went IPO on 2023-05-18. Monogram Orthopaedics Inc. (Monogram) is engaged in developing a product solution architecture for mass personalization of orthopedic implants by linking three-dimensional (3D) printing and robotics via automated digital image analysis algorithms. Its primary business is to market orthopedic implants insertable with its orthopedic robot. The company has a navigated robot prototype that can optically track a simulated surgical target and execute optimized auto-generated cut paths for precision insertion of implants in synthetic bone specimens. These implants and cut paths are generated with Monogram software algorithms. The Monogram technology platform consists of a workflow to prepare a patient-specific surgical plan from a computed tomography scan. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.

MGRM Intrinsic Value
Not Available
Back to Top